Anti CCP Assay
Ideal Serological Marker in Rheumatoid Arthritis
Misdiagnosis of Rheumatoid Arthritis (RA) has major medical and cost implications. A new, highly specific and sensitive second generation peptide based test enables early and accurate diagnosis of RA.
Diagnostic Accuracy: Anti-CCP is over 95% specific and present in 80% of RA sera- Present early in disease: Anti-CCP is present in most patients at first visit to the clinic
- Predicts disease outcome: Anti-CCP titers correlate with disease activity
- Fully automated on the DSX™ 4 plate ELISA system: Anti-CCP with increased productivity and consistent results
DSX™ is a trademark of Dynex Technologies Inc, Virginia, USA
Anti-CCP2 EIA in other countries
.jpg)